Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Acer Therapeutics Inc.

Conduct an FDA meeting to discuss the confirmatory evidence plan for EDSIVO

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
15 Jan 2021
Due
30 Jun 2021
Delivered
May 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“EDSIVO™ FDA meeting to discuss confirmatory evidence plan: H1 2021”

What we found

Evidence strength A What the grades mean

The company held a Type B meeting with the FDA in May 2021 to discuss the clinical trial design and confirmatory evidence plan for EDSIVO, meeting the H1 2021 deadline.

  • A
    Acer Therapeutics Inc. 10-K filed 2022-03-02 Regulatory filing · published 2 Mar 2022 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 6f9c8b487595
    “In a Type B meeting in May 2021, we discussed with FDA the conduct of an U.S.-based prospective, randomized, double-blind, placebo-controlled, decentralized clinical trial in patients with COL3A1+ vEDS” ✓ confirmed on the page

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory other
Indicative materiality
Medium rules
Action
Conduct
Deliverable
EDSIVO FDA meeting
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Acer Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-C069308-022135 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.